Dan Groman is CTO at Enfusion, Inc. (ENFN). They have made 6 open-market trades across 1 company since 2022, most recently 2023-11-14.
CIK 0001881296
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ENFN | 133,828 | $1.4M |
Shares reported on the most recent Form 4, priced at the 2023-11-16 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ENFN | SELL · 10b5-1 | 2023-11-14 | 2023-11-16 | $9.97 | $50K | -2.0% | -1.8% | -12.3% |
| ENFN | SELL · 10b5-1 | 2023-10-17 | 2023-10-19 | $9.09 | $45K | -6.0% | +11.1% | -1.2% |
| ENFN | SELL · 10b5-1 | 2023-09-19 | 2023-09-21 | $9.07 | $45K | -2.8% | -3.1% | +6.7% |
| ENFN | SELL | 2023-08-14 | 2023-08-15 | $7.89 | $14K | +7.4% | +9.8% | +22.5% |
| ENFN | SELL | 2023-08-11 | 2023-08-14 | $8.10 | $15K | +7.3% | +7.3% | +22.3% |
| ENFN | SELL | 2023-08-10 | 2023-08-11 | $8.08 | $17K | +8.0% | +10.3% | +13.4% |
| ENFN | SELL | 2023-08-09 | 2023-08-10 | $8.32 | $19K | +6.6% | +10.5% | +11.8% |
| ENFN | SELL · 10b5-1 | 2023-07-17 | 2023-07-19 | $11.31 | $44K | -4.0% | -27.3% | -19.4% |
| ENFN | SELL · 10b5-1 | 2023-06-20 | 2023-06-22 | $8.86 | $34K | +20.2% | +21.5% | +1.2% |
| ENFN | SELL · 10b5-1 | 2023-05-22 | 2023-05-24 | $7.92 | $427K | +4.4% | +16.4% | +7.6% |
| ENFN | SELL | 2023-05-10 | 2023-05-12 | $8.34 | $251K | -0.6% | +11.8% | +0.5% |
| ENFN | SELL · 10b5-1 | 2023-04-17 | 2023-04-19 | $9.66 | $37K | -4.8% | -12.7% | +25.5% |
| ENFN | SELL · 10b5-1 | 2023-03-17 | 2023-03-21 | $10.94 | $42K | +0.3% | -14.8% | -14.1% |
| ENFN | SELL · 10b5-1 | 2023-02-17 | 2023-02-22 | $10.93 | $42K | -6.4% | -4.3% | -29.2% |
| ENFN | SELL · 10b5-1 | 2023-01-17 | 2023-01-19 | $10.93 | $42K | +1.4% | -7.6% | -22.3% |
| ENFN | SELL | 2022-11-14 | 2022-11-16 | $13.91 | $239K | -21.5% | -29.7% | -13.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.